Hedgehog MedTech develops integrated digital therapeutics for headache sufferers, spanning mobile treatment applications, AI-driven diagnostic hardware, and disease-awareness programs. Its flagship assets include the headache management app "Zutool," the newly launched tele-medicine service "Zutool Doctor," and proprietary headache AI diagnostic devices. By connecting everyday user data with clinical care, the company positions itself as Japan’s first end-to-end headache platform provider. In August it signed a basic agreement to acquire Zutool and related services from Bellsystem24, with the business transfer completing on October 31, 2025. Post-transfer, Hedgehog MedTech intends to scale organizational capacity and accelerate new business development while exploring collaborations with strategic backer Medley. The company’s strength lies in its program medical device and digital therapeutics (DTx) expertise, enabling a fully integrated product suite for headache management. No revenue or user figures were disclosed in the article.

Total raised

$4M

Funding rounds

3

Latest round

Series A

Latest activity

Dec 2023